Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R/R > TREAT.: > USA. E. Non-Covalent (Reversible)>

---

USA. E. Non-Covalent (Reversible)>'s subsections
(*) USA Approval Date: 2023. 01.27
>2 Lines od Systemic Therapy>
>BTK Inhibitor Tablets
Company
Generic Name
TM
TM Web-Site
USA Patent Numbers

USA. E. Non-Covalent (Reversible)>'s products
This section has no products